Both Semaglutide and Mounjaro represent new strategies to managing type 2 diabetes, and increasingly, weight management. It is a dual receptor activator that impacts two receptors involved in metabolism: GLP-1 and GIP. https://bookmarkleader.com/story22256652/understanding-tirzepatide-mounjaro-a-comprehensive-overview